Hiles JJ, Kolesar JM.Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma Am [J].Health Syst Pharm,2008, 65(2): 123.
[2]
Hortodagyi GN,Frye D,BuzdarAU,et al.Decreased cardiac toxicity of doxorubicin administered by continuos intravenous infusion in combination chemotherapy for metastatic breast carcinoma.Cancer[J].Cacer Treat Rev,1989,63(1):37.
Komar AA.Silent SNPs:inpact on gene function and phenotype[J].Phatmacogenomics,2007,8(8):1075-1080.
[5]
Gardner ER,Figy WD,Sparreboom A.Pharmacogenomics of the human ATP-binging cassette transporter ABCG2[J].Curr Pharmacogenomics,2006,4(4):331-344.
[6]
Marzolini C,Paus E,Buclin T,et al.Polymorphisms in human MDR1(P-glycoprotein): recent advance and clinical relevance[J]. Clim Pharmacal Ther,2004,75: 13-14.
[7]
Mlleett Gonzalezke, Chen S. The CD44 receptor interacts with P-glycoprotein to promote cellmigration and invasion in cancer[J].Cancer Res, 2005, 65(15):6660-6667.
S Rybarova,I Hodorova,M Hakdukova,et al.Expression of MDR protein in breast cancer and its correlation with some clinical and pathological parameters[J].Neoplasma,2006; 53(2): 33-55.
